BOSENTAN RAN bosentan (as monohydrate) 125 mg film-coated tablet blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

bosentan monohydrate, Quantity: 129.083 mg

متاح من:

Sun Pharma ANZ Pty Ltd

INN (الاسم الدولي):

bosentan monohydrate

الشكل الصيدلاني:

Tablet, film coated

تركيب:

Excipient Ingredients: pregelatinised maize starch; magnesium stearate; maize starch; povidone; sodium starch glycollate type A; glycerol dibehenate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose

طريقة التعاطي:

Oral

الوحدات في الحزمة:

56, 60

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including Eisenmenger?s physiology,in patients with WHO functional Class II, III or IV symptoms

ملخص المنتج:

Visual Identification: The 125mg film-coated tablets are light peach to peach colored, oval shaped, biconvex & debossed with '125' on one side & plain on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

الوضع إذن:

Licence status A

تاريخ الترخيص:

2016-07-11